The coronavirus SARS-CoV-2 (i.e. COVID-19) pandemic is a global health crisis that requires the combined efforts and cooperation of both the public and private sectors. As COVID-19 continues to spread around the world, Verseon is committed to do its part to assist in addressing this global challenge to public health.

In line with Verseon’s mission to develop new medications that address areas of critical need, we will be using our proprietary computer-driven drug-discovery platform to design novel anti-viral drugs and to explore new anti-viral targets.

N95 respirator masks and immunological assays

In response to the immediate crisis, we are using our resources and business partnerships to secure medical supplies and diagnostic kits, including N95 respirator masks for personal protection and point-of-care immunological assays for the detection of SARS-CoV-2 in patients. We will be offering these supplies to designated healthcare providers and government agencies. Interested parties may contact us at for more information.

At Verseon we are committed to doing everything we can to assist the public during this difficult time.

More information

For more information on COVID-19, please consult your local and national health authorities.